397 related articles for article (PubMed ID: 23877823)
21. Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.
van Poppelen NM; de Bruyn DP; Bicer T; Verdijk R; Naus N; Mensink H; Paridaens D; de Klein A; Brosens E; Kiliҫ E
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396957
[TBL] [Abstract][Full Text] [Related]
22. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
23. The genetic basis of uveal melanoma.
Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic signaling in uveal melanoma.
Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
[TBL] [Abstract][Full Text] [Related]
25. Genetic landscape of uveal melanoma.
Rodrigues MJ; Stern MH
J Fr Ophtalmol; 2015 Jun; 38(6):522-5. PubMed ID: 25976133
[TBL] [Abstract][Full Text] [Related]
26. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
[TBL] [Abstract][Full Text] [Related]
27. Oncogene status as a diagnostic tool in ocular and cutaneous melanoma.
Griewank KG; Schilling B; Scholz SL; Metz CH; Livingstone E; Sucker A; Möller I; Reis H; Franklin C; Cosgarea I; Hillen U; Steuhl KP; Schadendorf D; Westekemper H; Zimmer L
Eur J Cancer; 2016 Apr; 57():112-7. PubMed ID: 26918736
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study.
Thomas S; Pütter C; Weber S; Bornfeld N; Lohmann DR; Zeschnigk M
Br J Cancer; 2012 Mar; 106(6):1171-6. PubMed ID: 22353812
[TBL] [Abstract][Full Text] [Related]
29. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
[TBL] [Abstract][Full Text] [Related]
30. Novel cell lines derived by long-term culture of primary uveal melanomas.
Nareyeck G; Zeschnigk M; Bornfeld N; Anastassiou G
Ophthalmologica; 2009; 223(3):196-201. PubMed ID: 19212147
[TBL] [Abstract][Full Text] [Related]
31. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
Glasgow BJ; McCannel TA
Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
[TBL] [Abstract][Full Text] [Related]
32. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.
Trolet J; Hupé P; Huon I; Lebigot I; Decraene C; Delattre O; Sastre-Garau X; Saule S; Thiéry JP; Plancher C; Asselain B; Desjardins L; Mariani P; Piperno-Neumann S; Barillot E; Couturier J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2572-80. PubMed ID: 19151381
[TBL] [Abstract][Full Text] [Related]
33. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
34. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
[TBL] [Abstract][Full Text] [Related]
35. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.
Martin M; Maßhöfer L; Temming P; Rahmann S; Metz C; Bornfeld N; van de Nes J; Klein-Hitpass L; Hinnebusch AG; Horsthemke B; Lohmann DR; Zeschnigk M
Nat Genet; 2013 Aug; 45(8):933-6. PubMed ID: 23793026
[TBL] [Abstract][Full Text] [Related]
36. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
37. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U
Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575
[TBL] [Abstract][Full Text] [Related]
38. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.
Johansson P; Aoude LG; Wadt K; Glasson WJ; Warrier SK; Hewitt AW; Kiilgaard JF; Heegaard S; Isaacs T; Franchina M; Ingvar C; Vermeulen T; Whitehead KJ; Schmidt CW; Palmer JM; Symmons J; Gerdes AM; Jönsson G; Hayward NK
Oncotarget; 2016 Jan; 7(4):4624-31. PubMed ID: 26683228
[TBL] [Abstract][Full Text] [Related]
39. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.
Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM
Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771
[TBL] [Abstract][Full Text] [Related]
40. [DEVELOPMENT AND CHALLENGES IN TREATMENT OF UVEAL MELANOMA].
Zloto O; Vishnevskia-Dai V; Moisseiev J; Fabian ID
Harefuah; 2018 Feb; 157(2):95-98. PubMed ID: 29484864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]